Computer-based de novo design of drug-like molecules.
Ever since the first automated de novo design techniques were conceived only 15 years ago, the computer-based design of hit and lead structure candidates has emerged as a complementary approach to high-throughput screening. Although many challenges remain, de novo design supports drug discovery projects by generating novel pharmaceutically active agents with desired properties in a cost- and time-efficient manner. In this review, we outline the various design concepts and highlight current developments in computer-based de novo design.
Schneider
Gisbert
G
Johann Wolfgang Goethe-University, Institute of Organic Chemistry and Chemical Biology, Marie-Curie-Str. 11 D-60439 Frankfurt am Main, Germany. gisbert.schneider@modlab.de
Fechner
Uli
U
D017076:Computer-Aided Design / Q000191:economics / Q000639:trends*; D015195:Drug Design; D008958:Models, Molecular; D013678:Technology, Pharmaceutical / Q000191:economics / Q000379:methods